Objective-To describe patterns of attendance for follow-up among HIV 
Introduction
Recent reports suggest that there has been a marked increase in heterosexually acquired Human Immunodeficiency Virus (HIV) in England, Wales and Northern Ireland, especially in London.1q The available evidence suggests that, in the majority of cases, these infections are acquired through heterosexual intercourse abroad (mostly in Africa). '-5 Patients from sub-Saharan Africa appear to represent a substantial proportion of infected individuals identified so far in London.24
The Government's recent White Paper6 has identified HIV/AIDS and Sexual Health as a key area within the national strategy for improving the health of the nation. The philosophy of the White Paper is to match targets with a strategy through which they might be achieved. The proportion of sub-Saharan African women attending for follow-up between three and 18 months was significantly smaller than that among both non sub-Saharan African women who had acquired infection heterosexually and women who had acquired infection through injecting drugs (p < 0.03). Married women were less likely to attend for follow-up, although the difference did not independent terms in the model. For the patient groups odds ratios for attendance were calculated against baseline attendance odds for the sub-Saharan African group. Both the non sub-Saharan group who acquired HIV heterosexually and the group who acquired HIV through injecting drug use were significantly more likely to attend than the sub-Saharan African group; for the non sub-Saharan group OR = 3-81 (95% CI: 1-08-13-4, p < 004), and for those with HIV acquired through injecting drug use OR = 3.79 (95% CI:100-14-3, p = 0.05). No other variable was significantly related to attendance.
Discussion
We have reported follow-up and characteristics of all women who were known or diagnosed to be infected with HIV when they presented to two Parkside Genitourinary Medicine clinics between March 1986 and March 1991. Overall 28% of women did not attend for follow-up at any time during the period studied. Only 52% of women of subSaharan African origin attended the clinics during the follow-up period, compared with 82% of non sub-Saharan African women who had acquired infection heterosexually and 83% of non sub-Saharan African women who had acquired infection through injecting drug use. Although sub-Saharan African women were more likely to be married and to have children, and less likely to have had a prior positive HIV test than the other groups, these did not explain the differences in follow-up observed between the groups.
Recent evidence suggests that the provision of health services for HIV seropositive patients may be poorly geared for women.' 01' Our findings emphasise the substantial proportions of HIV antibody positive women who are married (31%) and who have children (46%), although neither these factors, nor having symptoms of HIV infection or a prior positive HIV antibody test seem to influence attendance for follow-up. Women attending a genitourinary medicine clinic in London have expressed a preference for an all-female staffed multidisciplinary outpatient service.'0 Experience from one such service suggests that women diagnosed HIV antibody positive at the all-woman clinic show significantly higher rates of follow-up than those achieved among women diagnosed positive at a general GUM clinic." HIV antibody positive women have particular requirements for health care services which differ from those of HIV positive homosexual men; for example, obstetric, gynaecological and family planning services, the provision of creche facilities for children, and health care for those children that may also be infected with HIV.
We cannot say from this study why the poor rate of follow-up in sub-Saharan female patients should have occurred. Explanations may include cultural barriers, attendance at other clinics or travel abroad, greater preference for all-female staff, language difficulties, or greater social and work commitmnents. In particular, problems in the availability of medical care in patients' country of origin may lead to quite different perceptions of the degree of extremity of illness at which it is appropriate to seek medical care. Furthermore, the benefits of seeking care early may not be adequately appreciated.
We are concerned that HIV infected women may not be gaining access to appropriate health care. Greater efforts are required to ensure that appropriate messages and information about potential benefit of regular care are given during pre and post test counselling. In addition further studies are required to identify women's needs and the barriers to their attendance which will help us define the shape of more accessible and appropriate services provisions for these women. Given the increasing number of women who are identified as HIV antibody positive who are from sub-Saharan Africa, a particular focus on the needs of this group is urgently needed.
